Trial intelligence / Profile preview

DANCE trial of 6 versus 12 days of flucloxacillin for hospitalized cellulitis

NL-OMON45002Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of flucloxacillin in cellulitis and erysipelas (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Resolution of cellulitis at 14 days. Planned start Feb 2013; status: not yet recruiting.

02

Drugs

flucloxacillin
03

Conditions

cellulitiserysipelas

Beyond the preview

Go deeper on NL-OMON45002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON45002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call